Episode notes
In this episode, Lorenza Rimassa, Andrew Moon, and Jakob Kather discuss ways to enhance tumor board effectiveness. Lorenza emphasizes the importance of multidisciplinary collaboration, Andrew highlights patient representation, and Jakob explores the integration of AI. Listen to them as they engage in insightful exchanges, addressing questions and offering innovative solutions.
This episode is sponsored by Roche, a global pioneer in pharmaceuticals and diagnostics. Roche's goal is to partner with the HCC community to provide optimal care and treatment to patients with HCC by supporting the implementation of an MDT approach.